Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr. Kafui Dzirasa (2006) Dr. Yasushi Masuda (2004) Dr. Marco Pardo (2002) Dr. Vania Prado (2002) Dr. Amy Ramsey (2008) Dr. Bryan Roth (current) Dr. Ali Salahpour (2007) Dr. Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.

In 2018 I got married and moved to France, to join the Interdisciplinary Institute for Neurosciences In 2021 I became mum of a gorgeous baby girl, Elena.

University in Berlin/Germany and a Ph.D. in molecular pharmacology (supervisor: Bertil B Fredholm; 1998-2002 As a postdoc, he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003 -2005) and later with Roger J Summers (Monash University, Melbourne Australia, GPCR pharmacology; 2006 ) before starting his independent research team "Receptor Biology & Signalling" in 2008.

He completed a master’s degree in 2000 and a Ph.D. degree in 2003 with a particular interest in the cardiovascular

He received his B.S. in Chemistry from Duke University in 2016 where he worked in the lab of Dr.

She oversaw early discovery programs IL-23 p19 and IL23 p19/IL-17 bispecifics. She is an inventor on 39 issued U.S. patents including anti-PD-1 patents, 22 EP patents, and greater

He progressed through the ranks at Warwick to become an Associate Professor before leaving in 2015 to In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow

Ph.D. in molecular and cell biology at UConn and then joined Addgene as a Quality Control Scientist in 2015

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998-2003) and Heart and Stroke Foundation of Ontario Career Investigator (2003-2016). Jubilee Medal, in 2012. He has also received both Junior (2001) and Senior (2005) investigator awards from the Pharmacological

His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical Soc.); 2014 Goodman and Gilman Award; 2017 Tu Youyou Award; 2017 Smissman Award; 2023 Hershberg Award

GPCRs associated with obesity and other metabolic diseases, including GPR10, Melanocortin 4, Serotonin 2C Since 2021, Jacek has been working at Novo Nordisk at its research sites in the UK (Oxford) and the US

completed his undergraduate training at the University of New South Wales (UNSW) Sydney, Australia in 2016 Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the

Trejo joined the faculty in the Department of Pharmacology at the University of North Carolina in 2000 and then moved to UC San Diego School Medicine, Department of Pharmacology in 2008, where she quickly rose through the ranks to tenured professor in 2012. In 2014, she was appointed Vice-Chair of the Department of Pharmacology. The long-term goal of Dr. Trejo has been continuously funded by the NIH for >20 years and was a recipient of the prestigious American

glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis Published date August 15, 2023

N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5 Published date November 23 , 2023 Abstract "Inflammatory chemokines are often elevated in disease settings, where the largest group

started my independent lab at Northwestern University Medical School (1996) was recruited back to UCSF in 2003

In 2000, Dr. In 2007, Dr. Tall moved to the University of Michigan in 2016 as an Associate Professor of Pharmacology and is a current

technologies, labs, and companies in synthetic biology, functional genomics, and bioinformatics over the last 20 He is a Searle Scholar (2015), NIH New Innovator (2014), and received his ScD in Biological Engineering

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in 2015 From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit